S100A8 and neoplasm: S100A8 contributes to the tumor microenvironment by binding to Toll-like receptor 4 (TLR4) and the Receptor for Advanced Glycation End-products (RAGE), activating NF-κB and inducing the production of pro-inflammatory cytokines.